DOCU vs NBY · P/E 15, rev $1.71B vs $51.9M cap
DocuSign Inc (DOCU) versus NovaBay Pharmaceuticals Inc (NBY) — a side-by-side from cached financials, not a winner call.
DocuSign Inc (DOCU) is a software - application company listed on US.
NovaBay Pharmaceuticals Inc (NBY) is a biotechnology company listed on US.
Latest reported DOCU revenue for 2026-07-31 was $1.71B. Net income was $155.9M. DOCU currently screens at market cap $15.74B and trailing P/E 14.8.
NBY does not have a complete income-statement cache yet.
DOCU currently screens at market cap $15.74B and trailing P/E 14.8. NBY currently screens at market cap $51.9M.
Not investment advice. Open the DOCU and NBY stock pages for the full models.
Not investment advice.